Alembic Pharmaceuticals informs about press release

08 Mar 2022 Evaluate

Alembic Pharmaceuticals has informed the exchange that the Company's joint venture, Aleor Dermaceuticals has received US Food and Drug Administration (USFDA) Final Approval for Nystatin and Triamcinolone Acetonide Ointment USP, 100,000 units/gram. In this regard, the company has enclosed a press release.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

843.15 -9.15 (-1.07%)
29-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.50
Dr. Reddys Lab 1268.60
Cipla 1494.40
Zydus Lifesciences 904.00
Lupin 2079.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×